Skip to main content
Pangen Biotech Inc. logo

Pangen Biotech Inc. — Investor Relations & Filings

Ticker · 222110 ISIN · KR7222110009 KO Manufacturing
Open in API
Filings indexed 333 across all filing types
Latest filing 2023-01-06 Major Shareholding Noti…
Country KR South Korea
Listing KO 222110

About Pangen Biotech Inc.

https://pangen.com/layout/eng/home.php

Pangen Biotech Inc. is a biotechnology company specializing in the research, development, and manufacturing of biopharmaceuticals. The company utilizes its proprietary platform technologies, particularly those based on Chinese Hamster Ovary (CHO) cell lines, for the production of complex protein therapeutics. Its primary business activities include the development of a pipeline of biosimilar products, such as Erythropoietin (EPO) and Aflibercept. In addition to its own product pipeline, Pangen Biotech offers Contract Development and Manufacturing Organization (CDMO) services, providing expertise in cell line development and biopharmaceutical production to other firms. The company also supplies reagents and kits for research applications.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a mandatory regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership, specifically regarding a change in the largest shareholder and related party holdings. This type of filing is categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema, as it tracks significant ownership thresholds and changes in control.
2023-01-06 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (often referred to as a 5% rule filing). It details the acquisition of shares by Huons Co., Ltd. in Pangen Co., Ltd. This type of document is used to notify the market and regulators of significant changes in share ownership, which falls under the 'Major Shareholding Notification' category.
2023-01-06 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. It details changes in share ownership by a major shareholder (Huons Co., Ltd.) in the issuing company (Pangen Co., Ltd.) due to market purchases. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) as it tracks changes in significant share ownership levels.
2023-01-06 Korean
[기재정정]주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (often referred to as a 5% report). It details changes in share ownership by a major shareholder (Huons Co., Ltd.) in the company Pangen. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema, as it tracks significant ownership thresholds and changes.
2023-01-06 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a formal 'Notice of Extraordinary General Meeting of Shareholders' (주주총회소집공고) for Pangen Inc. It includes the meeting date, location, agenda items (election of directors and auditors), and detailed management reference materials (경영참고사항) regarding the company's business operations, market status, and financial activities. This document is a standard proxy statement/notice sent to shareholders to inform them of an upcoming meeting and provide necessary background information for voting. In the context of the provided categories, this fits the 'Proxy Solicitation & Information Statement' (PSI) classification.
2022-12-27 Korean
[기재정정]주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal regulatory filing from a Korean company (Pangen) regarding the 'Convocation of a General Meeting of Shareholders' (주주총회소집결의). It details the agenda for an upcoming Extraordinary General Meeting, including the appointment of directors and auditors. This type of document is a standard proxy solicitation/information statement provided to shareholders to inform them of meeting details and agenda items, which falls under the PSI category.
2022-12-22 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.